Friday, July 10, 2026

Drug profile · INN

clindamycin

clindamycin (APO-CLINDAMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — clindamycin

Quick answer

clindamycin (APO-CLINDAMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd.

Key facts

INN clindamycin
Brand APO-CLINDAMYCIN

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 23-01/ClindaTret-G Phase 3 · Alphapharm · Papulopustular acne
  2. APHP220763 Phase 3 · PARItec · Catheter related bloodstream infections due to Staphylococcu
  3. CLOU064J12301 Phase 3 · Novartis India · Hidradenitis Suppurativa (HS)
  4. CLOU064J12302 Phase 3 · Novartis India · Hidradenitis Suppurativa (HS)
  5. VACAB-2022 Phase 3 · George Institute for · Patients with hip or knee infections
  6. Clindamycin 300 mg capsule Phase 1 · Teva Pharma · Healthy

Frequently asked questions

What is clindamycin?

clindamycin (APO-CLINDAMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd.

What is the brand name for clindamycin?

APO-CLINDAMYCIN is a marketed brand name for clindamycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.